NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)
This grant funds research to develop and optimize new devices for brain and addiction disorders, supporting their progress toward readiness for initial human trials.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Estimated total funding: $6,000,000; ~4 awards expected; award size/duration not specified.
Summary: Supports translational development of next-generation diagnostic and therapeutic devices for neurological and addiction disorders, advancing technologies toward readiness for first-in-human trials.
Description
This forecasted opportunity invites applications for the translational development of next-generation diagnostic and therapeutic devices aimed at preventing, monitoring, diagnosing, or treating disorders within the missions of the NIH BRAIN Initiative and the HEAL Initiative. The program is focused on facilitating the translation of innovative device technologies to the point of readiness for first-in-human clinical trials by overcoming key technical and translational barriers identified during proof-of-concept studies. Supported activities may include technology development, optimization, and studies required to prepare for regulatory approvals for human use.
